Apeloa Pharmaceutical Co.,Ltd

Sümbol: 000739.SZ

SHZ

14.01

CNY

Turuhind täna

15.0522
P/E suhe
0.3216
PEG suhe
16.38B
MRK Cap
0.02%
DIV tootlus

Apeloa Pharmaceutical Co.,Ltd (000739-SZ) Finantsaruanded

Q: Mis on Apeloa Pharmaceutical Co.,Ltd (000739.SZ) koguvara?

Apeloa Pharmaceutical Co.,Ltd (000739.SZ) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Apeloa Pharmaceutical Co.,Ltd (000739.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 3072.75 M, mis on 0.225 % gowth. Kogu perioodi keskmine brutokasum on 793.225 M, mis on 0.491 %. Keskmine brutokasumi suhtarv on 0.211 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 0.067 %, mis on võrdne 0.341 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Apeloa Pharmaceutical Co.,Ltd fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.063. Käibevara valdkonnas on 000739.SZ aruandlusvaluutas 8368.16. Märkimisväärne osa neist varadest, täpsemalt 3580.687, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.008%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 174.047, kui neid on, aruandlusvaluutas. See näitab erinevust 90.595% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 18.694 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 3.093%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 6222.729 aruandlusvaluutas. Selle aspekti aastane muutus on 0.129%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 2420.562, varude hind on 2083.3 ja firmaväärtus 20.31, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 319.8.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	14812.83	3580.7	3552.9	2624.9	2310.4	1499.7	644	551.2	553	795.1	809.6	812.7	833.4	253.8	279.5	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1	7.8	5	5.5	5.9
balance-sheet.row.short-term-investments	-65.1	0	0.1	14.9	116.2	463.9	-7.2	4.2	-3.7	-4.1	1.9	2	1.9	1.7	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	10834.01	2420.6	2286.8	1804.6	1455	1377.5	1367.7	1488.4	1301.7	863.2	882	979.4	779.4	316.3	267	297.6	223.5	232.5	228.9	200.7	170.3	164.2	129.3	96.7	10.6	5.1	3.8	4.9	14.9	8.2	13.4
balance-sheet.row.inventory	7885.31	2083.3	1801.8	1249.9	1086.2	993	901	727.2	693.5	722.3	585.1	632.3	477.7	301.9	259.3	220.1	257.7	195.7	180.6	165.6	158.5	126.4	119.2	63.1	99.7	106.4	121.3	30	27.3	22.4	42.3
balance-sheet.row.other-current-assets	546.48	283.6	139.6	102.5	65.7	87.7	161.8	103.5	93.6	85.2	58.5	-40.1	-18.2	-2.8	-2.8	-9.6	-5.2	-4.8	-3.4	-5.4	-8.7	-9	-16	-14.8	70.3	80.2	67	26.8	-2.8	4.2	7.1
balance-sheet.row.total-current-assets	34078.64	8368.2	7781.1	5781.9	4917.4	3958	3074.5	2870.2	2641.8	2465.8	2335.2	2384.4	2072.2	869.1	803.1	756.5	756.1	925.8	653.9	498.8	540.7	413.2	262.9	162.4	194.2	265.1	215.1	69.6	44.5	40.3	68.6
balance-sheet.row.property-plant-equipment-net	14152.56	3617.4	3405.9	2682.9	1981.2	2017.8	2123.3	2286.8	2340.2	2306	2139.4	1758.9	1555.1	907	816.9	765.5	749.7	553.5	603.9	609.6	533	347.7	324.4	317.5	243.4	240.6	242.7	234.4	119.9	106	72.8
balance-sheet.row.goodwill	81.24	20.3	20.3	20.3	20.3	20.3	29.5	29.5	29.5	29.5	29.5	20.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1284.29	319.8	378.8	407.6	345.1	331.2	363.2	401.2	441.9	474.5	478.8	470.3	431.5	275.1	217.7	222.9	230.5	131.4	3.4	5.6	8	10.4	2.7	2.2	7.6	8.1	1.9	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	1365.53	340.1	399.1	427.9	365.4	351.5	392.7	430.7	471.4	504	508.3	490.6	451.8	275.1	217.7	222.9	230.5	131.4	3.4	5.6	8	10.4	2.7	2.2	7.6	8.1	1.9	0	0	0	0
balance-sheet.row.long-term-investments	715.76	174	91.3	66.4	5.5	-341.6	108.1	31.8	35.7	33.7	-1.4	-1.5	-1.4	-1.2	-1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	955.25	247.4	265.6	47.6	39.6	49	40.7	55.4	67	59.4	41.2	27.7	27.3	9.9	6.4	4.8	4.8	3.5	3.6	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	270.73	20.6	73.6	156.6	185.6	487.9	11.4	16.2	62.9	26.1	39.1	2.2	2.1	1.7	2.3	0	0	0	19.7	30.9	32.7	91.9	99.2	105.3	101.4	6.6	15.4	13.3	0	0	0.1
balance-sheet.row.total-non-current-assets	17459.84	4399.5	4235.5	3381.4	2577.4	2564.6	2676.2	2820.9	2977.2	2929.2	2726.6	2277.9	2035	1192.6	1041.5	993.2	985	688.4	630.6	646	573.7	449.9	426.4	425	352.4	255.3	260.1	247.7	119.9	106	72.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	51538.48	12767.7	12016.6	9163.3	7494.8	6522.6	5750.8	5691.1	5619	5394.9	5061.8	4662.3	4107.2	2061.8	1844.6	1749.7	1741.1	1614.1	1284.4	1144.9	1114.5	863.1	689.3	587.4	546.6	520.3	475.2	317.2	164.4	146.3	141.5
balance-sheet.row.account-payables	15550.44	2013.9	4310.6	2622.5	1928.7	2010.3	1113.3	933.9	1151.9	1333	1339.6	1109.7	1168.2	510.2	405	407.9	335.2	322.5	225.2	158	174.2	130.6	77.1	70.7	36.7	40.2	39.3	32.6	48.8	38.4	29.6
balance-sheet.row.short-term-debt	5990.9	3403.5	571.9	346.4	330.3	50	614.1	1088	1116.1	1033.1	758.8	1205.9	1242.6	551.5	495.7	420.2	470.2	369.2	383.1	333.2	352.2	203.2	264.7	154.2	117	86	34	20	6	18.2	21.1
balance-sheet.row.tax-payables	383.56	77	117.6	190.7	227.7	83.3	87.3	101	99.6	64.5	71.7	47	57.1	14.3	8.4	10.5	8.1	7.6	16.5	10.4	5.5	9.4	7	6.9	2.5	5.1	13.2	5.2	7.1	10	3.4
balance-sheet.row.long-term-debt-total	267.11	18.7	265.4	127.9	0	72	72	72	180	196.6	172	167	37.5	38.5	0	0	60	90	130	140	140	110	0	40	0	0	0	0	30	17.2	34.3
Deferred Revenue Non Current	132.38	30.6	15.1	119.8	125.4	119.8	130.1	129.8	100.9	98.7	95.4	83.6	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	418.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1435.26	460	685.9	18	5.8	140.5	388.9	75.1	77.3	53.6	70.8	80.7	34.9	27	17.6	13.6	29.4	28.2	22.6	15.9	9.8	6.1	5.2	3.7	54.3	58.5	77.2	1.2	0.5	0.5	0.2
balance-sheet.row.total-non-current-liabilities	1079.97	198.9	470.8	324	207.7	193	202.8	203.7	353.7	296.3	268.4	242.8	111.5	76.4	16.4	18.7	65.4	93.8	130	140	145.4	122.3	0	40	3.6	3.2	2.3	1.4	30.6	17.5	34.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	32.69	4.5	15.8	22.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	27012.14	6506.6	6497.4	4103.3	3104.1	2754.6	2406.5	2641.1	3002.5	2978.1	2755.9	2804.4	2741.6	1255.1	1036	954.9	973	864	828.7	732.9	743.4	534.2	402.9	327.7	231.5	212.4	227.2	95.8	114.2	98.5	106.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	4714.09	1178.5	1178.5	1178.5	1178.5	1178.5	1178.5	1178.5	1146.9	1146.9	1146.9	815.5	374.5	256.7	256.7	256.7	256.7	256.7	145.7	145.7	145.7	145.7	145.7	145.7	145.7	145.7	75.6	63	32.6	18.4	18.4
balance-sheet.row.retained-earnings	17750.62	4520	3854.5	3240.1	2608.8	2018.8	1619.6	1340.1	1172.9	981.8	876.8	575.1	408.9	164.4	161.3	143.2	114.5	86.8	111.4	76.9	54.8	37.2	14.2	-66.4	-5.3	-10.9	20.6	0.7	0	15.5	5.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	1206.9	288.3	243	205.3	167.3	134.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	793.7	235.9	235.9	436.1	436.1	436.1	546.2	531.4	296.7	288.1	282.3	401.8	567.8	372.3	372.3	371.7	371.4	370.1	159.8	149.7	133.4	122.6	111.4	167.7	173.2	171.4	151	157.8	17.5	13.9	11.3
balance-sheet.row.total-stockholders-equity	24465.32	6222.7	5511.9	5060	4390.7	3768	3344.3	3050	2616.5	2416.7	2305.9	1792.3	1351.1	793.4	790.3	771.6	742.7	713.6	417	372.3	334	305.6	271.4	247.1	313.7	306.2	247.2	221.5	50.1	47.8	35.3
balance-sheet.row.total-liabilities-and-stockholders-equity	51538.48	12767.7	12016.6	9163.3	7494.8	6522.6	5750.8	5691.1	5619	5394.9	5061.8	4662.3	4107.2	2061.8	1844.6	1749.7	1741.1	1614.1	1284.4	1144.9	1114.5	863.1	689.3	587.4	546.6	520.3	475.2	317.2	164.4	146.3	141.5
balance-sheet.row.minority-interest	30.39	7.7	7.3	0	0	0	0	0	0	0.1	0	65.5	14.4	13.3	18.3	23.2	25.4	36.5	38.8	39.6	37.1	23.3	15	12.6	1.4	1.7	0.8	0	0	0	0
balance-sheet.row.total-equity	24495.71	6230.4	5519.2	5060	4390.7	3768	3344.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	51538.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	650.66	174	91.4	81.2	121.7	122.2	100.9	36	32	29.6	0.5	0.5	0.5	0.5	0.5	0	0	0	23.3	27.3	31.2	91.7	99.2	105.2	99	4.9	13.3	0	0	0	0
balance-sheet.row.total-debt	6262.49	3426.7	837.3	474.3	330.3	50	614.1	1088	1296.1	1229.8	930.8	1372.9	1280.1	590	495.7	420.2	530.2	459.2	513.1	473.2	492.2	313.2	264.7	194.2	117	86	34	20	36	35.4	55.4
balance-sheet.row.net-debt	-8550.35	-154	-2715.6	-2135.7	-1864	-985.8	-29.9	541	743.1	434.7	123	562.2	448.6	338	218.5	171.9	250.1	-43.1	265.2	335.3	271.5	181.6	234.3	176.9	103.4	12.6	10.9	12.2	31	29.9	49.5

Rahavoogude aruanne

Apeloa Pharmaceutical Co.,Ltd finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -0.509 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 130.17 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -676422944.000. See on 0.144 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 558.97, 0, -96.52, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -347.29 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 141.95, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1059.75	1055.3	989.2	955.6	816.7	553.4	370.6	256.6	262.9	208.2	326.7	161	134.6	3.2	20	32.9	26	27.8	51.1	46.1	37.5	36.7	34	-26	7.5	7.6	25.7
cash-flows.row.depreciation-and-amortization	-0.82	559	389.4	358.6	353.8	353.5	329.4	331.6	302	286.2	247.8	227.5	193.3	100.5	90.1	82.3	66.4	52.4	53.1	44.4	37.7	33.5	27.3	4.1	6.1	6.1	4.5
cash-flows.row.deferred-income-tax	0	3.6	-104	-14	18.4	-7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-1932.7	104	14	-18.4	7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-908.1	-777.9	-165.8	-682.1	-74.1	360.7	40.7	-482.6	-433.5	-144.8	193	-293.4	-84.6	44.2	-13.3	55.6	-39.9	57	7.7	-33.2	-49.3	13.7	-84.3	12.6	-1.5	-40.3	-2.4
cash-flows.row.account-receivables	-571.63	-571.6	-1108.1	-851.4	-176.8	-294.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-373.35	-373.3	-603.1	-190.1	-116.9	-124.9	-207.5	-60.2	6	-168.8	29.4	-163.2	2.4	-43.1	-39.3	37	-69.8	-10.5	-15.2	-8	-22.2	-7.9	-56.1	22	13.4	-3.3	-15.8
cash-flows.row.account-payables	0	130.2	1649.3	373.4	201.1	787.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	36.87	36.9	-104	-14	18.4	-7.8	248.2	-422.3	-439.5	24	163.6	-130.1	-87	87.3	26	18.6	29.9	67.5	22.9	-25.2	-27	21.5	-28.2	-9.4	-14.9	-37	13.4
cash-flows.row.other-non-cash-items	937.72	2124.1	113.3	-20.3	-36.9	92.4	92	104.2	49	91.5	19.2	95.3	92.7	33.8	24.2	37.5	42.1	37	47.5	30.1	21.6	21.5	25.8	8.7	-5.1	6	2.2
cash-flows.row.net-cash-provided-by-operating-activities	1088.54	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-634.54	-630.5	-509.1	-701.9	-317.1	-31.8	-81.6	-163.4	-331.4	-452.1	-540.2	-505	-339.6	-289.2	-139.8	-93.7	-349	-115.7	-53.8	-121.7	-111.1	-88.1	-47.2	-1	-3.2	-7.8	-16.4
cash-flows.row.acquisitions-net	46.96	39.7	12.2	3.9	16.7	-1	16.3	246.7	14.5	11.8	22.9	-1.6	352	0	5	0	0	-4.3	0	0	1.9	0	0	0	3.2	7.8	0
cash-flows.row.purchases-of-investments	-161.37	-172.9	-389	-446.9	-424.5	-864	-356.5	-196.9	-34	-48.5	34.9	-8.4	-0.5	0	-52.8	0	0	0	0	0	-28.2	0	0	0	-92.9	-3	0
cash-flows.row.sales-maturities-of-investments	87.26	87.3	383.2	559.1	821.8	516.9	257.1	197.6	34.2	47.8	11	1	0.6	0	50	0	0	0	0	0	61.1	0	0	6.3	4.2	11.4	0
cash-flows.row.other-investing-activites	-8.73	0	-88.6	70.5	9.5	-60.9	-14.3	-163.4	16.9	0	-0.2	9.9	-339.6	28.3	1.1	1	1.2	4.1	1.7	4.4	11.9	35.4	11.6	8.1	-3.2	-7.8	0
cash-flows.row.net-cash-used-for-investing-activites	-670.42	-676.4	-591.3	-515.4	106.4	-440.8	-179	-79.4	-299.8	-441	-471.6	-504.1	-327.1	-261	-136.5	-92.7	-347.9	-116	-52.1	-117.3	-64.4	-52.7	-35.6	13.4	-91.9	0.6	-16.4
cash-flows.row.debt-repayment	-814.12	-96.5	-712.7	-698.2	-204	-944.1	-1639	-1675.5	-1454.8	-1081.4	-1880.5	-1368.8	-1901.1	-675	-634.6	-500	-281	-391.9	-101	-59	-290.5	-271	-199.6	-75.8	-79.8	-38.2	-13
cash-flows.row.common-stock-issued	0	0	200.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	-200.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-386.19	-347.3	-362.8	-301.9	-201.4	-142.1	-119.8	-141.6	-129.4	-162.5	-88.2	-75.4	-84.7	-40.2	-31.2	-37.4	-39.9	-44.7	-39.4	-30.6	-24.5	-18.3	-24.6	-10.3	-6	-1.8	-12.4
cash-flows.row.other-financing-activites	913.9	141.9	879.4	795.8	484.1	380	1165.1	1724.6	1631.5	1286.6	1644.8	1821.4	2031.8	769.3	710.1	390	352	632.8	143	36.7	421.1	337.8	270.1	77	110.9	110.2	27
cash-flows.row.net-cash-used-provided-by-financing-activities	-366.84	-301.9	-196.1	-204.3	78.7	-706.2	-593.7	-92.5	47.3	42.6	-323.8	377.2	46.1	54.1	44.3	-147.4	31.1	196.2	2.6	-52.9	106.1	48.5	45.9	-9.1	25	70.2	1.6
cash-flows.row.effect-of-forex-changes-on-cash	39.7	27.5	44	-17.3	-38.3	3.3	7.3	-14.4	18.4	10.1	-0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-0.36	27.8	582.8	-125.3	1206.4	216.4	67.2	23.4	-53.6	52.9	-9.6	63.5	54.9	-25.2	28.9	-31.8	-222.2	254.5	109.9	-82.8	89.2	101.1	13.1	3.7	-59.8	50.3	15.3
cash-flows.row.cash-at-end-of-period	11369.38	3580.7	2381.9	1799.2	1924.4	718.1	501.4	434.1	410.7	464.4	411.5	421.1	357.5	252.1	277.2	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1
cash-flows.row.cash-at-beginning-of-period	11369.75	3552.9	1799.2	1924.4	718.1	501.7	434.1	410.7	464.4	411.5	421.1	357.5	302.6	277.2	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1	7.8
cash-flows.row.operating-cash-flow	1088.54	1031.4	1326.1	611.7	1059.5	1360.1	832.7	209.8	180.4	441.2	786.6	190.4	335.9	181.7	121	208.3	94.6	174.2	159.4	87.4	47.5	105.4	2.8	-0.6	7.1	-20.5	30.1
cash-flows.row.capital-expenditure	-634.54	-630.5	-509.1	-701.9	-317.1	-31.8	-81.6	-163.4	-331.4	-452.1	-540.2	-505	-339.6	-289.2	-139.8	-93.7	-349	-115.7	-53.8	-121.7	-111.1	-88.1	-47.2	-1	-3.2	-7.8	-16.4
cash-flows.row.free-cash-flow	454	400.9	817	-90.2	742.4	1328.2	751.1	46.4	-150.9	-10.9	246.4	-314.6	-3.7	-107.5	-18.8	114.6	-254.5	58.5	105.6	-34.3	-63.5	17.3	-44.4	-1.6	3.9	-28.3	13.7

Kasumiaruande rida

Apeloa Pharmaceutical Co.,Ltd tulud muutusid võrreldes eelmise perioodiga 0.083%. 000739.SZ brutokasum on teatatud 2731.52. Ettevõtte tegevuskulud on 1649.39, mille muutus võrreldes eelmise aastaga on 13.274%. Kulud amortisatsioonikulud on 558.97, mis on 0.020% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 1649.39, mis näitab 13.274% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.070% kasvu võrreldes eelmise aastaga. Tegevustulu on 1082.12, mis näitab 0.070% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 0.067%. Eelmise aasta puhaskasum oli 1055.34.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	11567.99	11418.1	10544.9	8942.6	7879.7	7210.7	6376.4	5551.8	4772.2	4337.9	4232.8	3899.8	3480.1	1534.5	1521	1367.9	1250.4	1041.5	1148.6	1035.4	830.5	770.3	659.3	141.8	178.8	225.6	418.1	367.7	368.7	344.3	331.2
income-statement-row.row.cost-of-revenue	8770.97	8686.6	8024.2	6569.3	5676.6	4876.6	4340.5	3839.9	3444.3	3149.7	3131.4	3017	2672.7	1236.9	1201.1	1068.9	1011.5	845.8	915.4	833.4	671.4	611.2	511	130.7	156.6	187.1	366.3	313.1	313.6	294.6	288
income-statement-row.row.gross-profit	2797.01	2731.5	2520.7	2373.3	2203	2334.1	2035.9	1711.9	1327.9	1188.2	1101.4	882.8	807.4	297.6	319.9	298.9	238.9	195.7	233.1	202	159.1	159	148.3	11.1	22.3	38.5	51.8	54.6	55	49.7	43.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	557.97	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	64.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	676.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-39.69	-42	313.2	264.7	216.9	269.6	-30.8	3.9	74.4	66.8	28.7	22.7	27.1	16.1	7.2	3.9	1.2	6.6	2.5	1.7	1.5	0.7	2.4	7.5	16.7	13.9	19.8	7.1	5.8	6.4	4.1
income-statement-row.row.operating-expenses	1686	1649.4	1456.1	1287.3	1251.2	1608.4	1516.6	1255.7	1015.5	913.4	744.9	634.9	550.1	252.7	250.4	218	173.5	132.6	139.1	125.2	90.2	90.5	78.5	32.7	36	39.8	35.4	29.4	35.8	33.5	31.3
income-statement-row.row.cost-and-expenses	10456.97	10336	9480.3	7856.7	6927.9	6484.9	5857.1	5095.6	4459.8	4063.1	3876.3	3651.9	3222.9	1489.6	1451.5	1286.9	1185	978.5	1054.6	958.6	761.6	701.8	589.5	163.4	192.5	226.9	401.7	342.5	349.4	328.1	319.4
income-statement-row.row.interest-income	-22.64	113.6	75.8	75.3	24.9	7.3	5.4	4.2	8.9	12.2	19.3	17.2	11.2	3.6	2.9	4.8	6.8	3.2	4	1.3	1	1.9	1.9	0.1	0.9	0	0	0	0	0	0
income-statement-row.row.interest-expense	34.1	47.2	59.2	35.7	16	30.2	42	62.1	62.3	66.1	80.2	82.1	107.6	40.4	37.7	36.2	34.8	37.6	33.7	23.7	17.8	13.5	16.4	8.6	6.3	2.8	1.6	0.8	5.1	4.4	2
income-statement-row.row.selling-and-marketing-expenses	676.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	66.36	119.3	0.4	-5.3	-8.6	-10.4	-57.1	-116.5	22.9	-27.8	20.7	-42.2	-88.9	-41.1	-42.1	-43.2	-38	-31.8	-35.9	-28.4	-21.7	-19.7	-19.9	-11.9	4.2	-1.8	2.4	3.7	-5.1	-4.5	-2.2
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-39.69	-42	313.2	264.7	216.9	269.6	-30.8	3.9	74.4	66.8	28.7	22.7	27.1	16.1	7.2	3.9	1.2	6.6	2.5	1.7	1.5	0.7	2.4	7.5	16.7	13.9	19.8	7.1	5.8	6.4	4.1
income-statement-row.row.total-operating-expenses	66.36	119.3	0.4	-5.3	-8.6	-10.4	-57.1	-116.5	22.9	-27.8	20.7	-42.2	-88.9	-41.1	-42.1	-43.2	-38	-31.8	-35.9	-28.4	-21.7	-19.7	-19.9	-11.9	4.2	-1.8	2.4	3.7	-5.1	-4.5	-2.2
income-statement-row.row.interest-expense	34.1	47.2	59.2	35.7	16	30.2	42	62.1	62.3	66.1	80.2	82.1	107.6	40.4	37.7	36.2	34.8	37.6	33.7	23.7	17.8	13.5	16.4	8.6	6.3	2.8	1.6	0.8	5.1	4.4	2
income-statement-row.row.depreciation-and-amortization	238.89	559	548	460.3	338.9	407.6	329.4	331.6	302	286.2	247.8	227.5	193.3	100.5	90.1	82.3	66.4	52.4	53.1	44.4	37.7	33.5	27.3	4.1	6.1	6.1	4.5	-5.9	-0.7	-2.1	-2.3
income-statement-row.row.ebitda-caps	1379.21	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1140.32	1082.1	1011.6	1119.4	969.7	644.2	490.5	335.7	273.6	202.3	343.1	185.5	143.6	-11.4	21.2	34.6	26.7	25.4	61.4	52.9	48.6	50.7	49.9	-25	4.9	8.9	30.6	31.1	20	18.3	14.1
income-statement-row.row.income-before-tax	1206.68	1201.4	1012.1	1114.1	961.2	633.7	462.2	339.6	335.3	247	377.2	205.7	168.3	3.8	27.3	37.8	27.4	31.3	61	51.5	48.7	50.1	51.1	-25.5	6	9.9	34.6	33.5	20	18.2	13.9
income-statement-row.row.income-tax-expense	149.86	149.3	22.9	158.5	144.4	80.3	91.6	83	72.4	38.8	50.5	44.8	33.7	0.6	7.3	4.9	1.4	3.4	9.8	5.4	11.2	13.4	17.2	0.5	-1.5	2	8.5	10.5	5.7	5.2	3.4
income-statement-row.row.net-income	1059.75	1055.3	989.2	955.6	816.7	553.4	370.6	256.6	262.9	208.2	322.2	167.4	137.1	8.2	23.8	34.1	29.1	30.4	52	43.8	35.6	34.2	31.6	-25.9	7.5	7.6	25.7	23	14.2	13	10.6